Intramuscular (IM) B12 injections using hydroxocobalamin, the preferred licensed form in the UK are recommended when: Oral supplementation has failed to correct a documented deficiency The patient has difficulty adhering to daily oral regimens Serum B12 levels remain persistently low despite adequate oral dosing There is clinical evidence of neurological or haematological complications In line with BNF guidance, the standard IM regimen for confirmed deficiency without neurological involvement is a loading course of 1 mg hydroxocobalamin on alternate days for two weeks , followed by maintenance of 1 mg every three months
[5] Revolution Health and Wellness (2025)
Its benefits include: Inhibiting pro-inflammatory cytokines, which is beneficial for Crohns disease, ulcerative colitis, and autoimmune disorders
Science Advances , 9 (27), eadg9593
The data presented in this table clearly demonstrate the increased stability of the BPC peptide salts of the present invention in contrast to free BPC peptide or its monoacetate
The only products that break from refrigeration are the two oral capsule formats